Related Experiment Videos
A new device to limit extravasation during contrast-enhanced CT
1Department of Surgery, University of Massachusetts Medical Center, Worcester 01655, USA.
AJR. American Journal of Roentgenology
|February 5, 2000
Summary
The extravasation detection accessory (EDA) reliably halted contrast injection during CT scans, preventing large extravasations. While not 100% sensitive, it significantly reduced contrast material delivery during extravasation events.
Area of Science:
- Radiology and Imaging Technology
- Medical Device Innovation
- Patient Safety in Interventional Procedures
Background:
- Contrast extravasation during CT scans poses a risk of patient injury.
- Power injectors deliver contrast media rapidly, increasing extravasation potential.
- Existing methods for detecting extravasation are limited.
Purpose of the Study:
- To evaluate the sensitivity and reliability of the Extravasation Detection Accessory (EDA) in a simulated contrast extravasation model.
- To determine the effectiveness of the EDA in halting power injector function during extravasation.
- To assess the potential of the EDA to minimize contrast volume delivered during extravasation events.
Main Methods:
- An EDA device was tested on subjects with simulated extravasation using nonionic and ionic contrast equivalents.
- Infusions were conducted at varying rates: 0.25 ml/sec, 2.5 ml/sec, and 5 ml/sec.
- The EDA's ability to detect extravasation and halt the power injector was recorded.
Main Results:
- The EDA successfully halted the injector in all tested subjects at 2.5 ml/sec and 5 ml/sec infusion rates.
- At 0.25 ml/sec, the EDA initially failed in 11 of 20 events but, after algorithm reprogramming, halted 18 of 20 events.
- The average delivered volume before halting was significantly reduced after algorithm adjustment at the lowest rate.
Conclusions:
- The Extravasation Detection Accessory demonstrates reliable and reproducible performance in halting power injectors during simulated contrast extravasation.
- The device shows promise in reducing the volume of contrast material delivered during extravasation, potentially minimizing patient morbidity.
- Further refinement may be needed to achieve 100% sensitivity across all injection rates.